Imatinib recommended as first post-surgery treatment for gastrointestinal stromal tumours

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2009年 / 70卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [1] Is there a role for post-imatinib surgery in advanced gastrointestinal stromal tumours?
    Kuhlmann, K. F. D.
    Kerst, J. M.
    Cats, A.
    van Coevorden, F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A3 - A3
  • [2] Treatment of gastrointestinal stromal tumours: imatinib, sunitinib - and then?
    Nilsson, Bengt
    Nilsson, Ola
    Ahlman, Hakan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 457 - 468
  • [3] Imatinib MesylateIn the Treatment of Gastrointestinal Stromal Tumours
    Katherine F. Croom
    Caroline M. Perry
    Drugs, 2003, 63 : 513 - 522
  • [4] Imatinib mesylate - In the treatment of gastrointestinal stromal tumours
    Croom, KF
    Perry, CM
    DRUGS, 2003, 63 (05) : 513 - 522
  • [5] Imatinib mesylate in treatment of advanced gastrointestinal stromal tumours
    Petricevic, B
    Vrbanec, D
    Belev, B
    Plestina, S
    Herceg, D
    Dedic-Plavetic, N
    ANNALS OF ONCOLOGY, 2005, 16 : 313 - 313
  • [6] Surgery for gastrointestinal stromal tumour in the post-imatinib era
    Neuhaus, SJ
    Clark, MA
    Hayes, AJ
    Thomas, JM
    Judson, I
    ANZ JOURNAL OF SURGERY, 2005, 75 (03) : 165 - 172
  • [7] Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib
    Gunhild Mechtersheimer
    Gerlinde Egerer
    Manfred Hensel
    Ralf J. Rieker
    Martin Libicher
    Thomas Lehnert
    Roland Penzel
    Virchows Archiv, 2004, 444 : 108 - 118
  • [8] Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours
    Daniel M. Huse
    Margaret von Mehren
    Gregory Lenhart
    Heikki Joensuu
    Charles Blanke
    Weiwei Feng
    Stan Finkelstein
    George Demetri
    Clinical Drug Investigation, 2007, 27 : 85 - 93
  • [9] Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib
    Mechtersheimer, G
    Egerer, G
    Hensel, M
    Rieker, RJ
    Libicher, M
    Lehnert, T
    Penzel, R
    VIRCHOWS ARCHIV, 2004, 444 (02) : 108 - 118
  • [10] Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours
    Huse, Daniel M.
    von Mehren, Margaret
    Lenhart, Gregory
    Joensuu, Heikki
    Blanke, Charles
    Feng, Weiwei
    Finkelstein, Stan
    Demetri, George
    CLINICAL DRUG INVESTIGATION, 2007, 27 (02) : 85 - 93
12345